PAM
Panagora Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,780
| Closed | -$10K | – | 1858 |
|
|
2021
Q2 | $10K | Sell |
1,780
-7,363
| -81% | -$41.4K | ﹤0.01% | 2251 |
|
|
2021
Q1 | $42K | Sell |
9,143
-7,266
| -44% | -$33.4K | ﹤0.01% | 2210 |
|
|
2020
Q4 | $55K | Sell |
16,409
-1,159
| -7% | -$3.89K | ﹤0.01% | 2022 |
|
|
2020
Q3 | $52K | Hold |
17,568
| – | – | ﹤0.01% | 2004 |
|
|
2020
Q2 | $81K | Hold |
17,568
| – | – | ﹤0.01% | 1850 |
|
|
2020
Q1 | $67K | Sell |
17,568
-239,171
| -93% | -$912K | ﹤0.01% | 1814 |
|
|
2019
Q4 | $963K | Sell |
256,739
-43,314
| -14% | -$162K | ﹤0.01% | 1067 |
|
|
2019
Q3 | $1.59M | Buy |
300,053
+2,815
| +0.9% | +$14.9K | 0.01% | 836 |
|
|
2019
Q2 | $1.14M | Hold |
297,238
| – | – | 0.01% | 1077 |
|
|
2019
Q1 | $1.52M | Sell |
297,238
-312,811
| -51% | -$1.6M | 0.01% | 954 |
|
|
2018
Q4 | $1.17M | Sell |
610,049
-1,401
| -0.2% | -$2.69K | 0.01% | 1008 |
|
|
2018
Q3 | $2.31M | Buy |
611,450
+333,821
| +120% | +$1.26M | 0.01% | 787 |
|
|
2018
Q2 | $866K | Buy |
277,629
+222,885
| +407% | +$695K | ﹤0.01% | 1192 |
|
|
2018
Q1 | $131K | Buy |
+54,744
| New | +$131K | ﹤0.01% | 1789 |
|
|
2015
Q4 | – | Sell |
-15,023
| Closed | -$45K | – | 2313 |
|
|
2015
Q3 | $45K | Sell |
15,023
-58,988
| -80% | -$177K | ﹤0.01% | 2018 |
|
|
2015
Q2 | $306K | Sell |
74,011
-50,388
| -41% | -$208K | ﹤0.01% | 1505 |
|
|
2015
Q1 | $539K | Buy |
+124,399
| New | +$539K | ﹤0.01% | 1292 |
|